Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CV Sciences, Inc. (CVSI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CV Sciences, Inc. (CVSI), most recent 12 months reported: revenue $12.74M, net loss $2.01M, free cash flow -$522K. Latest balance sheet on file: liquid cash $266K. From SEC filings. Others in Pharmaceutical Preparations: EMMAUS LIFE SCIENCES, INC. · Keros Therapeutics, Inc. · Pyxis Oncology, Inc. · PALATIN TECHNOLOGIES, INC. · CRESCENT BIOPHARMA, INC. · BIOAGE LABS, INC. · Evommune, Inc. · Zenas BioPharma, Inc.

Stock screener

Watchlist